Virtual reality is rapidly emerging as a powerful tool for managing pain, anxiety, and distress in clinical settings, but a new study reveals that the technology’s success may hinge on a surprisingly low-tech factor: a brief, supportive conversation with a clinician. The randomized feasibility pilot, published in JMIR XR and Spatial Computing, shows that the way VR therapeutics are introduced to patients can significantly sway their engagement, adherence, and overall acceptance—even when the hardware and software remain identical across groups.
While the therapeutic potential of VR has been touted for years, most research has zeroed in on clinical endpoints rather than the messy realities of implementation. This study intentionally eschewed efficacy metrics, instead isolating the onboarding process to understand how different support strategies shape early user behavior. Thirty-one adults with minimal prior VR experience were sorted into three distinct pathways: unguided use, where participants simply received a preloaded headset and minimal instructions; self-directed support, which supplemented the device with quick-start guides, an in-app tutorial, and access to a troubleshooting chatbot; and provider-led support, which combined those self-directed materials with a scripted, five-minute consultation from a trained clinician who simulated a prescription, screened for safety, fitted the device, and guided the initial setup.
The results were striking. Participants who experienced the provider-supported onboarding demonstrated significantly greater time-based adherence to the VR therapeutic protocol—a metric that directly reflects how faithfully patients followed the intended usage schedule—compared to those in the unguided group (P = .04). They also logged longer overall engagement durations, suggesting that the human touch at the outset may prime patients to invest more fully in the digital intervention. Even the self-directed support group, armed with extensive asynchronous resources, could not match the impact of a single, standardized face-to-face interaction lasting only five minutes.
Technology acceptance, measured through validated scales, improved markedly across all cohorts after a brief exposure to the VR therapy (P < .001). However, the final scores remained in a moderate range, indicating that while initial perceptions shift quickly, they require ongoing reinforcement to solidify into lasting adoption. This finding underscores that a one-time instruction, no matter how skilled, is but the first step in a longer journey of digital therapeutic integration.
The advantage of clinician involvement extended to usability and error rates. Observational data revealed that participants in the provider-led group committed fewer operational mistakes and rated the system’s usability more favorably. They also exhibited less early frustration and apprehension—emotional states that are known to undermine technology acceptance and long-term habit formation. The human-guided setup appeared to defuse the anxiety that often accompanies unfamiliar hardware, transforming a potentially intimidating experience into something manageable.
Importantly, the VR intervention was well tolerated across the board. Cybersickness levels remained low, and no participant discontinued the study because of adverse effects. This suggests that the technology itself is not a barrier; rather, the barrier lies in the ecosystem of support surrounding its deployment.
“Virtual reality therapeutics are often talked about in terms of clinical outcomes, but real-world adoption depends on much more than whether the technology works,” said lead author Ashlyn Zebrowski, a researcher at the University of North Carolina at Chapel Hill. Zebrowski, who was recognized with a 2025 JMIR Publications Early Career Researcher Award for this work, emphasized that even a brief provider interaction can alter how patients perceive the legitimacy of the therapy and their own competence in using it. Qualitative findings from the study bore this out: participants described the clinician’s involvement as conferring a sense of clinical legitimacy and setting clear expectations, which in turn reshaped their entire approach to the technology.
The study’s implications extend far beyond VR. As digital therapeutics—software-based treatments that deliver evidence-based interventions—proliferate across healthcare, the question of how to embed them into clinical workflows becomes paramount. A beautifully designed app or an immersive virtual environment may count for little if patients feel abandoned during the first moments of use. The findings challenge the prevailing assumption that self-explanatory design and automated support can fully substitute for human interaction, at least in the vulnerable context of healthcare. They also raise provocative questions about the role of clinicians: rather than being disintermediated by technology, providers may need to be upskilled as guides and coaches for the digital layer of care.
The research team, spanning informatics, nursing, radiation oncology, and exercise science at UNC-Chapel Hill and Montana State University, acknowledges the pilot nature of the study and calls for larger trials to test whether improved early adoption translates into durable clinical benefits. Yet the message is already clear: the pathway to scaling VR therapeutics—and likely other digital health tools—must be designed with as much rigor as the interventions themselves. A five-minute conversation might just be the cheapest and most effective accelerant of that journey.
Subject of Research: People
Article Title: Evaluating the Effects of Clinician Prescribing and Implementation Materials on Adoption of Virtual Reality Therapeutics: Randomized Feasibility Pilot Study
News Publication Date: July 7, 2026
Web References: https://doi.org/10.2196/90626
References: Zebrowski A, Fernandez R, Pinkelton C, Kitzmiller R, Kiefer A, Stanley L, Mody G, Moore C, Mazur L. JMIR XR Spatial Comput 2026;3:e90626. DOI: 10.2196/90626
Image Credits: Ashlyn Zebrowski, PhD
Keywords: Virtual reality, Artificial intelligence, Medical treatments, Health care, Ergonomics, Biomedical engineering, Engineering, Health and medicine
